Skip to main content

Testosterone Gel Lawsuit

testosterone gel lawsuitTestosterone replacement therapy, which includes testosterone gels, is growing in popularity among older males as a result of aggressive pharmaceutical advertisements that boast testosterone gels as being the solution to aging and low testosterone, or Low T. Though these advertisements carefully deliver a life-changing offer, they fail to tell the whole story about testosterone gel products, among them, Androgel, a testosterone gel manufactured by AbbVie, and Axiron, a testosterone gel manufactured by Eli Lilly & Co.

Among testosterone gel side effects are cardiovascular complications. These complications include heart attack, stroke, and coronary artery disease. Testosterone gels have also been linked to an increased risk for prostate cancer, especially in older patients.

In addition to placing the patient’s health at risk, testosterone gels, because they require topical application, can affect the health of people with whom the patient comes into close contact.

Women who have come into contact with men who use testosterone gels have experienced side effects that include unusual hair growth and distribution and an increase in acne. For children, exposure to testosterone gels can lead to aggressive behavior, enlarged genitalia, accelerated puberty, and bone aging.

Testosterone Lawsuit Assistance

As a law firm with experienced personal injury lawyers, Carey Danis & Lowe is well-known for offering exceptional testosterone lawsuit assistance. If you and your family have been harmed by testosterone gels, rest assured that Carey Danis & Lowe will work tirelessly towards recovering your losses.

Our professional defective drug litigation team is currently accepting testosterone gel cases. Please contact our law offices today for a free case evaluation. There is no cost or commitment on your part for this initial case evaluation.

You can reach Carey Danis & Lowe by phone at 800.721.2519, or by submitting a confidential personal injury claim form.